BG Medicine, Inc.  

(Public, OTCMKTS:BGMD)   Watch this stock  
Find more results for NASDAQ:BGMD
0.240
+0.015 (6.67%)
Jun 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.19 - 0.24
52 week 0.17 - 2.77
Open 0.22
Vol / Avg. 27,757.00/14,987.00
Mkt cap 2.73M
P/E     -
Div/yield     -
EPS -0.74
Shares 11.37M
Beta 2.53
Inst. own 8%
Apr 29, 2016
Q4 2015 BG Medicine Inc Earnings Release
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -311.03% -338.63%
Operating margin -311.03% -295.66%
EBITD margin - -290.10%
Return on average assets -131.82% -144.06%
Return on average equity - -
Employees 5 -
CDP Score - -

Address

880 Winter St Ste 210
WALTHAM, MA 02451-1465
United States - Map
+1-781-8901199 (Phone)
+1-302-6365454 (Fax)

Website links

Description

BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Officers and directors

Paul R. Sohmer M.D. President, Chief Executive Officer, Director
Age: 66
Stephen P. Hall Chief Financial Officer, Executive Vice President, Treasurer
Age: 64
Aram Adourian Ph.D. Senior Vice President, Chief Scientific Officer
Age: 45
Jeffrey R. Luber J.D. Director
Age: 49
James F. O Connor CPA Director
Age: 74
Harry W. Wilcox III Director
Age: 61
Stelios B. Papadopoulos Ph.D. Independent Director
Age: 67